Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. (Q34706643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

József Tímár

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Károly Lapis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Anna Sebestyén

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

László Kopper

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Ilona Kovalszky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Cancer Biology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

173-186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Heparan sulfate proteoglycans in invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Molecular pathology of tumor metastasis. I. Predictive pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Lumican and decorin are differentially expressed in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorin

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Decorin-induced Growth Suppression Is Associated with Up-regulation of p21, an Inhibitor of Cyclin-dependent Kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Decorin is a biological ligand for the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

An Anti-oncogenic Role for Decorin

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Expression of a decorin-like moleculein human melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Role of Proteoglycans in Tumor Progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Glypicans: proteoglycans with a surprise

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Glypicans in growth control and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Molecular diversity of heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Glypican-3 expression is silenced in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Expression of a glypican-related 62-kDa antigen is decreased in hepatocellular carcinoma in correspondence to the grade of tumor differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Syndecans: transmembrane modulators of adhesion and matrix assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Syndecan-regulated receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Protein kinase C regulates the recruitment of syndecan-4 into focal contacts

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Syndecan-1 expression has prognostic significance in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Syndecans and the lymphoid system

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Clinical implications of anomalous CD44 gene expression in neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Homing receptors and the control of lymphocyte migration

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

CD44 in inflammation and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

CD44 binds a chondroitin sulfate proteoglycan, aggrecan

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Serum CD44 in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Gains and losses of CD44 expression during breast carcinogenesis and tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Antigens of melanocytes and melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Coordinate role for cell surface chondroitin sulfate proteoglycan and alpha 4 beta 1 integrin in mediating melanoma cell adhesion to fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Expression of the chondroitin sulphate proteoglycan molecular complex in six human melanoma xenograft lines studied by flow cytometry and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Active specific immunotherapy of malignant melanoma and peptide mimics of the human high-molecular-weight melanoma-associated antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Heparan sulfate proteoglycan expression in human lung-cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Proteoglycans and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

The Hedgehog and Wnt signalling pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Heparan sulfate: growth control with a restricted sequence menu

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. II. Cytochemical and biochemical evidence for differences in glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Modulation of heparan-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Inhibition of metastases by anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

Actions of heparin that may affect the malignant process

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900021-4

7 January 2021

10.1016/S1044-579X(02)00021-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12083848%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference